Abstract:Background: Preclinical studies have shown that maternal gut microbiota during pregnancy play a key role in prenatal immune development but the relevance of these findings to humans is unknown. The aim of this prebirth cohort study was to investigate the association between the maternal gut microbiota in pregnancy and the composition of the infant's cord and peripheral blood immune cells over the first year of life. Methods: The Barwon Infant Study cohort ( n =1074 infants) was recruited using an unselected sampling frame. Maternal fecal samples were collected at 36 weeks of pregnancy and flow cytometry was conducted on cord/peripheral blood collected at birth, 6 and 12 months of age. Among a randomly selected sub-cohort with available samples ( n =293), maternal gut microbiota was characterized by sequencing the 16S rRNA V4 region. Operational taxonomic units (OTUs) were clustered based on their abundance. Associations between maternal fecal microbiota clusters and infant granulocyte, monocyte and lymphocyte subsets were explored using compositional data analysis. Partial least squares (PLS) and regression models were used to investigate the relationships/associations between environmental, maternal and infant factors, and OTU clusters. Results: We identified six clusters of co-occurring OTUs. The first two components in the PLS regression explained 39% and 33% of the covariance between the maternal prenatal OTU clusters and immune cell populations in offspring at birth. A cluster in which Dialister, Escherichia , and Ruminococcus were predominant was associated with a lower proportion of granulocytes ( p =0.002), and higher proportions of both central naïve CD4 + T cells (CD4 + /CD45RA + /CD31 − ) ( p <0.001) and naïve regulatory T cells (Treg) (CD4 + /CD45RA + /FoxP3 low ) ( p =0.02) in cord blood. The association with central naïve CD4 + T cells persisted to 12 months of age. Conclusion: This birth cohort study provides evidence consistent with past preclinical models that the maternal gut microbiota during pregnancy plays a role in shaping the composition of innate and adaptive elements of the infant's immune system following birth.

The maternal gut microbiome in pregnancy: implications for the developing immune system

The Role of Microbiomes in Pregnant Women and Offspring: Research Progress of Recent Years

The Role of Microbiota in Infant Health: from Early Life to Adulthood

The Maternal–Fetal Gut Microbiota Axis: Physiological Changes, Dietary Influence, and Modulation Possibilities

Composition and interaction of maternal microbiota with immune mediators during pregnancy and their outcome: A narrative review

Maternal gut microbiota in the health of mothers and offspring: from the perspective of immunology

Maternal-Foetal/Infant Interactions—Gut Microbiota and Immune Health

Maternal gut microbiota during pregnancy and the composition of immune cells in infancy

The microbiome in pregnancy and early life-Highlights from the 11th Maria Delivoria-Papadopoulos Perinatal Symposium

Maternal and early life exposures and their potential to influence development of the microbiome

Host–gut microbiota interactions during pregnancy

The Impact of Maternal Gut Microbiota during Pregnancy on Fetal Gut–Brain Axis Development and Life-Long Health Outcomes

The microbiome and development: a mother's perspective.

Recent Insights on the Maternal Microbiota: Impact on Pregnancy Outcomes

The Unique Microbiome and Innate Immunity During Pregnancy

Influence of maternal microbiota during pregnancy on infant immunity

Microbiome and pregnancy: focus on microbial dysbiosis coupled with maternal obesity

Maternal Microbe-Specific Modulation of the Offspring Microbiome and Development During Pregnancy and Lactation

From gut to placenta: understanding how the maternal microbiome models life-long conditions

How nutrition and the maternal microbiota shape the neonatal immune system

The importance of gut microbiome in the perinatal period